Holen Sie sich die Stockscreener-App
150.17
0.74%
1.11
Vorhandelsmarkt:
150.17
Schlusskurs vom Vortag:
$149.06
Offen:
$147.52
24-Stunden-Volumen:
770.57K
Relative Volume:
0.85
Marktkapitalisierung:
$8.45B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-484.42
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
-6.78%
1M Leistung:
+0.97%
6M Leistung:
+6.12%
1J Leistung:
+8.34%
1-Tages-Spanne:
$146.42
$150.84
1-Wochen-Bereich:
$144.18
$166.62
52-Wochen-Spanne:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
150.17 | 8.39B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen (NASDAQ:RGEN) Cut to Hold at Wall Street Zen - Defense World
Relative strength of Repligen Corporation in sector analysis2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Smart tools for monitoring Repligen Corporation’s price actionJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
How Repligen Corporation stock performs during Fed tightening cyclesProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Does Repligen Corporation stock trade at a discount to peersPortfolio Risk Summary & Daily Stock Trend Watchlist - newser.com
Should you hold or exit Repligen Corporation nowJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Can volume confirm reversal in Repligen Corporation2025 Dividend Review & Short-Term High Return Ideas - newser.com
What technical patterns form on Repligen Corporation (RGN) stock chartsEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Pier Capital LLC Sells 4,692 Shares of Repligen Corporation $RGEN - MarketBeat
Geneva Capital Management LLC Purchases 343,991 Shares of Repligen Corporation $RGEN - MarketBeat
Research Analysts Offer Predictions for Repligen Q1 Earnings - Defense World
William Blair Has Negative View of Repligen FY2025 Earnings - MarketBeat
Custom strategy builders for tracking Repligen CorporationJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
William Blair Forecasts Reduced Earnings for Repligen - Defense World
FY2025 EPS Estimates for Repligen Cut by Leerink Partnrs - MarketBeat
Will Repligen Corporation (RGN) stock hit Wall Street targetsWeekly Trade Review & Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-31 03:24:45 - newser.com
Repligen Corp (RGEN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... By GuruFocus - Investing.com Canada
Applying chart zones and confluence areas to Repligen CorporationWeekly Trade Analysis & Verified Momentum Stock Alerts - newser.com
Published on: 2025-10-29 21:31:23 - newser.com
Barclays Maintains Repligen (RGEN) Overweight Recommendation - Nasdaq
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset - Yahoo Finance
Is Repligen Corporation stock attractive for ETFsJuly 2025 Recap & Verified Swing Trading Watchlist - newser.com
What makes Repligen Corporation stock attractive to growth funds2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
Repligen: Q3 Earnings Snapshot - Stamford Advocate
Repligen shares rise 3% as Q3 revenue growth tops expectations - Investing.com
Earnings call transcript: Repligen Q3 2025 earnings beat expectations, stock rises - Investing.com Canada
Repligen Raises Outlook After Beating Revenue And Earnings Forecasts - Finimize
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Repligen Corp Q3 2025 Earnings: EPS of $0.26 Beats Estimates, Re - GuruFocus
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates - Yahoo Finance
Repligen earnings beat by $0.04, revenue topped estimates - Investing.com
Repligen Q3 2025 Earnings Beat Estimates, Raises Full-Year OutlookNews and Statistics - IndexBox
Repligen Corporation Reports Q3 2025 Financial Results - TradingView
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - Yahoo Finance
Bessemer Group Inc. Sells 2,485 Shares of Repligen Corporation $RGEN - MarketBeat
Using data tools to time your Repligen Corporation exitJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
How Repligen Corporation stock compares to growth peersLong Setup & Short-Term Trading Opportunity Alerts - fcp.pa.gov.br
Earnings To Watch: Repligen Corp (RGEN) Reports Q3 2025 Result - Yahoo Finance
Is it time to cut losses on Repligen CorporationMarket Activity Recap & Weekly Sector Rotation Insights - newser.com
Will Repligen Corporation stock benefit from infrastructure spendingJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
Repligen Earnings: What To Look For From RGEN - Barchart.com
Weiss Ratings Reaffirms Sell (D) Rating for Repligen (NASDAQ:RGEN) - MarketBeat
Technical signs of recovery in Repligen CorporationJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Best Manufacturing Stocks To Watch TodayOctober 23rd - MarketBeat
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):